CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma

NCT00634751 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Neoplasms
Bile Duct Neoplasms

Interventions

DRUG: Oxaliplatin
DRUG: Capecitabine
DRUG: Sorafenib

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]
[object Object]